NCT04528914

Brief Summary

This single-center, randomized, controlled, quadruple-blinded, superiority trial is performed to test the hypothesis that children with IBS and FAP-NOS who receive a low-FODMAP diet will have a lower mean abdominal pain intensity score compared with those who receive a regular diet after 4 weeks of intervention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 27, 2020

Completed
2.6 years until next milestone

Study Start

First participant enrolled

April 2, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

August 1, 2025

Status Verified

February 1, 2025

Enrollment Period

1.7 years

First QC Date

August 19, 2020

Last Update Submit

July 29, 2025

Conditions

Keywords

functional abdominal pain disordersirritable bowel syndromediet

Outcome Measures

Primary Outcomes (1)

  • Change in abdominal pain intensity

    The primary outcome will be the percentage of the responders, defined as the participants who have at least 30% improvement in abdominal pain intensity on a 100-mm Visual Analogue Scale (VAS) during the last week of the trial compared with baseline, that is at least equal to the Reliable Change Index (≥ 25 mm change on VAS).

    At week 1, 2, 3 and 4 from baseline.

Secondary Outcomes (11)

  • Change in stool consistency

    At week 1, 2, 3 and 4 from baseline.

  • Change in abdominal pain frequency

    At week 1, 2, 3 and 4 from baseline.

  • Change in Gastrointestinal Symptom Rating Scale (GSRS) total score

    At week 1, 2, 3 and 4 from baseline.

  • Change in KIDSCREEN-10 index total score

    At week 1, 2, 3 and 4 from baseline.

  • Change in World Health Organization Five Well-Being Index (WHO-5) total score

    At week 1, 2, 3 and 4 from baseline.

  • +6 more secondary outcomes

Study Arms (2)

Low-FODMAP diet

EXPERIMENTAL

37 participants.

Other: Low-FODMAP diet

Regular diet

NO INTERVENTION

37 participants. The regular diet will reflect the habitual FODMAP intake in a normal diet. Diets in both groups will be matched in terms of total energy, fat, protein, carbohydrates and dietary fiber with the usual participant's diet.

Interventions

The low-FODMAP diet will contain the amount of FODMAPs that will not exceed the cut-offs for each FODMAP sugar per serving of food per sitting. Diets will be individually tailored by dietitian and delivered by a catering company (five meals each day).

Low-FODMAP diet

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • functional abdominal pain - not otherwise specified (FAP-NOS) or irritable bowel syndrome (IBS) diagnosed according to the Rome IV Criteria,
  • baseline average pain intensity at least 30 mm on a 100-mm Visual Analogue Scale,
  • feeding via the oral route,
  • ability to read and comprehend any employed questionnaires/scales,
  • signed informed consent,
  • stated availability throughout the study period.

You may not qualify if:

  • receiving any other intervention/treatment with regard to FAP-NOS or IBS or those who received any other intervention during the last 3 months,
  • an organic cause of symptoms or organic gastrointestinal disease,
  • chronic illness, receiving medications which affect gastrointestinal motility,
  • need for any other dietary management which could make the balancing or compliance with the diet troublesome,
  • undernutrition (defined as World Health Organization \[WHO\] growth charts \< -2 SD), decreased growth velocity (sharp decline in growth line), or overweight or obese (\> 1 or \> 2 SD on the WHO growth charts, respectively),
  • unintentional weight loss greater or equal to 5% of subject' body weight within the previous 3 months,
  • pregnancy,
  • eating disorders,
  • prior surgery of the gastrointestinal tract (within last 3 months),
  • recurrent or unexplained fever,
  • developmental disabilities which impair the ability of the child to understand or communicate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Paediatrics, The Medical University of Warsaw

Warsaw, Poland

Location

Related Publications (1)

  • Strozyk A, Horvath A, Muir J, Szajewska H. Effect of a low-FODMAP diet for the management of functional abdominal pain disorders in children: a study protocol for a randomized controlled trial. Nutr J. 2021 Jan 2;20(1):1. doi: 10.1186/s12937-020-00656-3.

MeSH Terms

Conditions

Irritable Bowel Syndrome

Interventions

FODMAP Diet

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Elimination DietsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The research investigators, outcome assessor, and independent statistician (data analyst) will be blinded until the completion of the data analysis.The dietitian will remain unblinded. Success of blinding will be assessed after completion of the follow-up period.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2020

First Posted

August 27, 2020

Study Start

April 2, 2023

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

August 1, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

The datasets used and/or generated during this study will be made available after the publication of results, no later than 3 years from the completion of data analysis.

Shared Documents
CSR
Time Frame
Up to 3 years after completion of data analysis.
Access Criteria
The datasets will be made available from the contact author upon reasonable request.

Locations